Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6701 Fannin St
Houston, TX 77030Phone+1 832-822-4240Fax+1 832-825-4247
Summary
- Dr. Lisa L. Wang is a pediatric oncologist at Baylor College of Medicine in Houston, TX. She completed her residency in Pediatrics at Children's Hospital Los Angeles and a fellowship in Pediatric Hematology/Oncology at Baylor College of Medicine/Texas Children's Hospital. She graduated from the University of North Carolina at Chapel Hill School of Medicine in 1993. Dr. Wang's publications cover topics including osteosarcoma, Rothmund-Thomson syndrome and related cancer predisposition syndromes, and cancer screening in children with genomic instability disorders. She has been involved in clinical trials focused on sarcoma and Rothmund-Thomson Syndrome. She is a Fellow of the American Academy of Pediatrics.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1997 - 2000
- Children's Hospital Los AngelesResidency, Pediatrics, 1993 - 1996
- University of North Carolina at Chapel Hill School of MedicineClass of 1993
Certifications & Licensure
- TX State Medical License 1999 - 2027
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Calcium Absorption in Patients With Rothmund-Thomson Syndrome Start of enrollment: 2011 Mar 01
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- IC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma
Publications & Presentations
PubMed
- 1 citationsUpdate on Recommendations for Cancer Screening and Surveillance in Children with Genomic Instability Disorders.Yoshiko Nakano, Roland P Kuiper, Kim E Nichols, Christopher C Porter, Harry Lesmana
Clinical Cancer Research. 2024-11-15 - 1 citationsSystematic transcriptome profiling of hPSC-derived osteoblasts unveils CORIN's mastery in governing osteogenesis through CEBPD modulation.Dandan Zhu, Mo-Fan Huang, An Xu, Xueqin Gao, Yu-Wen Huang
The Journal of Biological Chemistry. 2024-08-01 - 7 citationsBiallelic variants in CRIPT cause a Rothmund-Thomson-like syndrome with increased cellular senescence.Luisa Averdunk, Maxim A Huetzen, Daniel Moreno-Andrés, Reinhard Kalb, Shane McKee
Genetics in Medicine. 2023-07-01
Other
- Osteosarcoma: Epidemiology, pathogenesis, clinical presentation, diagnosis, and histologyWang LL, Gebhardt MC, Chintagumpala M
http://www.uptodate.com/contents/osteosarcoma-epidemiology-pathogenesis-clinical-presentation-diagno
UpToDate, Wolters Kluwer Health - 2012-05-31
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: